EXO-NET
LIVE

Serial Number

79274531

Owner

Sienna Cancer Diagnostics Ltd

Attorney

Charles G. Zug

Filing Date

Nov 8, 2019

Add to watchlist:

No watchlists yet
View on USPTO

EXO-NET Trademark

Serial Number: 79274531 • Registration: 6248000

EXO-NET is a trademark filed by Sienna Cancer Diagnostics Ltd on November 8, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Sienna Cancer Diagnostics Ltd (2 trademarks)

C/- BARD1 Life Sciences Ltd,

Entity Type: 83

Trademark Details

Filing Date

November 8, 2019

Registration Date

January 19, 2021

Published for Opposition

November 3, 2020

Goods & Services

Pharmaceutical preparations and substances for the treatment and/or diagnosis of cancer and infectious diseases; biotechnologically-formed enzyme preparations for medical purposes; medicinal preparations for the treatment of cancer and infectious diseases; monoclonal antibodies for therapeutic purposes; products containing antibodies for use in medicine, namely, diagnostic kits consisting primarily of monoclonal antibodies used in the capture of exosomes and other extra cellular vesicles for use in disease testing; proteins for binding antibodies for medical use; proteins for detecting antibodies for medical use; reagents for medical use, namely, for use in the development of monoclonal antibodies; diagnostic biomarker reagents for medical purposes; tagged antibodies for medical use; vaccines; vaccines against cancer, viral, and bacterial infection; vaccines for human use; diagnostic preparations and reagents for medical purposes; vaccine adjuvants; diagnostic preparations, reagents, and substances for medical purposes; diagnostic products and testing materials for medical purposes, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in capturing and purifying exosomes and other extra cellular vesicles for use in disease testing; reagents for use in diagnostic tests for medical purposes; medical diagnostic reagents for capturing and purifying exosomes and other extra cellular vesicles that can be utilised in therapeutics or diagnostics; cells for growing recombinant human protein for medical purposes; recombinant DNA technology proteins for medical use; biological reagents for use in molecular biology, namely, reagents for medical use for capturing and purifying exosomes and other extra cellular vesicles that contain nucleic acid; antibodies that are specifically able to bind and capture exosomes and other extra cellular vesicles for medical purposes; antibody fragments that are specifically able to bind and capture exosomes and other extra cellular vesicles for medical purposes; antibody conjugates that are specifically able to bind and capture exosomes and other extra cellular vesicles for medical purposes; pharmaceutical preparations for the treatment, reconstruction and repair of antibodies; immunological antibodies for medical use; monoclonal antibodies for medical diagnostic use; monoclonal antibodies for medical use

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 19, 2026 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
May 16, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 24, 2021 FICS
FINAL DISPOSITION PROCESSED
Apr 23, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 19, 2021 FICR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 29, 2021 ADCH
REGISTERED-PRINCIPAL REGISTER
Jan 19, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 3, 2020 NPUB
PUBLISHED FOR OPPOSITION
Nov 3, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Nov 2, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 14, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 14, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 14, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 24, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 10, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 9, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 9, 2020 TROA
REFUSAL PROCESSED BY IB
Mar 27, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 9, 2020 RFCS
REFUSAL PROCESSED BY MPU
Mar 9, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 19, 2020 RFCR
NON-FINAL ACTION WRITTEN
Feb 18, 2020 CNRT
ASSIGNED TO EXAMINER
Feb 12, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 27, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 23, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 19, 2019 REPR